- CA$63.16m
- CA$78.46m
- CA$0.41m
- 28
- 13
- 57
- 24
Annual balance sheet for MedMira, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.402 | 0 | 0.033 | 0.013 | 2.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.208 | 1.25 | 1.37 | 1.43 | 1.33 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.911 | 1.58 | 1.66 | 1.69 | 3.68 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.48 | 2.31 | 2.17 | 1.96 | 2.39 |
Net Intangible Assets | |||||
Total Assets | 3.4 | 3.89 | 3.83 | 3.65 | 6.07 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15.8 | 17.4 | 14.1 | 15.7 | 21 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 19 | 19.6 | 16.2 | 18.7 | 24.1 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -15.6 | -15.7 | -12.4 | -15 | -18 |
Total Liabilities & Shareholders' Equity | 3.4 | 3.89 | 3.83 | 3.65 | 6.07 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |